The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
123486032 12348603 2 F 20160725 20160509 20160801 EXP CA-PFIZER INC-2016245088 PFIZER 0.00 F Y 0.00000 20160801 MD CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
123486032 12348603 1 SS ENBREL ETANERCEPT 1 UNK U 0
123486032 12348603 2 PS XELJANZ TOFACITINIB CITRATE 1 UNK U 203214 TABLET
123486032 12348603 3 SS CELEBREX CELECOXIB 1 UNK U 20998 CAPSULE, HARD
123486032 12348603 4 SS CELEBREX CELECOXIB 1 U 20998 CAPSULE, HARD
123486032 12348603 5 SS METHOTREXATE SODIUM. METHOTREXATE SODIUM 1 UNK U 11719
123486032 12348603 6 SS ACTEMRA TOCILIZUMAB 1 UNK U 0
123486032 12348603 7 SS CORTISONE CORTISONEHYDROCORTISONE 1 UNK U 0
123486032 12348603 8 SS FOLIC ACID. FOLIC ACID 1 UNK U 0
123486032 12348603 9 SS HUMIRA ADALIMUMAB 1 Subcutaneous UNK U 0
123486032 12348603 10 SS ORENCIA ABATACEPT 1 UNK U 0
123486032 12348603 11 SS PREDNISONE. PREDNISONE 1 Unknown UNK U 0
123486032 12348603 12 SS REMICADE INFLIXIMAB 1 Intravenous (not otherwise specified) UNK U 0
123486032 12348603 13 SS RITUXAN RITUXIMAB 1 Intravenous (not otherwise specified) UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
123486032 12348603 1 Rheumatoid arthritis
123486032 12348603 2 Rheumatoid arthritis
123486032 12348603 3 Arthritis
123486032 12348603 4 Rheumatoid arthritis
123486032 12348603 5 Rheumatoid arthritis
123486032 12348603 6 Rheumatoid arthritis
123486032 12348603 7 Rheumatoid arthritis
123486032 12348603 8 Rheumatoid arthritis
123486032 12348603 9 Rheumatoid arthritis
123486032 12348603 10 Rheumatoid arthritis
123486032 12348603 11 Rheumatoid arthritis
123486032 12348603 12 Rheumatoid arthritis
123486032 12348603 13 Rheumatoid arthritis

Outcome of event

Event ID CASEID OUTC COD
123486032 12348603 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
123486032 12348603 Activities of daily living impaired
123486032 12348603 Drug ineffective

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found